Chemotherapy is systemic therapy, different chemotherapy drugs for various tissues and organs have different side effects 翻译结果2复制译文编辑译文朗读译文返回顶部 Chemotherapy is systemic therapy, chemotherapy drugs for various organizations in different organs have different side effects 翻译结果3复制译文编辑...
such as the mode of chemotherapy, drug delivery methods and means a lot to explore and try, hoping to find to improve the effectiveness of chemotherapy to improve the quality of life of patients with anticancer drugs. With research and development of sustained 解决这些问题,许多学者从不同方面,例...
More than two dozen different drugs, from old-line chemotherapy drugs to malaria drugs, might work against the baffling new MERS virus.NBC News
A non-invasive method for detection of intestinal mucositis induced by different classes of chemotherapy drugs in the rat. Cancer Biol. Ther. 2006; 5: 1189-95.Howarth G.S., Tooley K.L., Davidson G.P., Butler R.N. (2006) A non-invasive method for detection of intestinal mucositis ...
These internists arecancerspecialists. They dochemotherapytreatments and often work withradiationoncologists and surgeons to care for someone withcancer. Ophthalmologists You call themeyedoctors. They can prescribe glasses orcontact lensesand diagnose and treat diseases likeglaucoma. Unlike optometrists, they...
This observation suggested that inhibitors targeting FOXO1 and JUN have the potential to be considered as therapeutic drugs for the PUC and CIS, for which chemotherapy options are deemed unsuitable. Taken together, our study has revealed that these two types (PUC and CIS) of potential precursor ...
Immune checkpoint inhibitors (ICIs) have been approved for monotherapy and combined therapy with chemotherapy and/or radiotherapy in China since 2018. The number of patients receiving ICIs has significantly increased in recent years, and the collection and analysis of this data are crucial for a comp...
While some patients with TNBC initially respond well to standardchemotherapy, these tumors are more likely to recur after treatment and have a poorer prognosis (less than 30 percent of women with metastatic TNBC – which has spread outside the breast – survive 5 years). ...
Tumor heterogeneity with, different because of different genetic background in cancer patients on anti-cancer drug response vary. Mostly experience currently on the clinical use of drugs, chemotherapy is not constant in many patients, neglected individual differences and blindness, and total ineffic ...
treated with these drugs often develop a new EGFR mutationcalled T790Mthat confers resistance to most EGFR inhibitors. However, researchers havedeveloped another drugthat inhibits proteins with T790M and other EGFR mutations more broadly, improving survival for patients with these types of lung cancers....